KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Equity Ratio: 2017-2024

Historic Equity Ratio for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to -0.59.

  • Aquestive Therapeutics' Equity Ratio rose 93.92% to -0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was -0.03, marking a year-over-year increase of 93.92%. This contributed to the annual value of -0.59 for FY2024, which is 68.02% up from last year.
  • Aquestive Therapeutics' Equity Ratio amounted to -0.59 in FY2024, which was up 68.02% from -1.85 recorded in FY2023.
  • Aquestive Therapeutics' Equity Ratio's 5-year high stood at -0.59 during FY2024, with a 5-year trough of -2.08 in FY2022.
  • Over the past 3 years, Aquestive Therapeutics' median Equity Ratio value was -1.85 (recorded in 2023), while the average stood at -1.51.
  • As far as peak fluctuations go, Aquestive Therapeutics' Equity Ratio slumped by 888.63% in 2020, and later soared by 68.02% in 2024.
  • Yearly analysis of 5 years shows Aquestive Therapeutics' Equity Ratio stood at -0.77 in 2020, then slumped by 71.79% to -1.32 in 2021, then crashed by 56.79% to -2.08 in 2022, then rose by 10.72% to -1.85 in 2023, then soared by 68.02% to -0.59 in 2024.